‘Drug Discovery for 1,000, Please’ | GenomeWeb

The New York Times' Steve Lohr reports at the Bits blog that IBM is using Watson-style software as part of it's "Strategic Intellectual Property Insight Platform," a cloud-based service resulting from "several years of joint development between IBMResearch and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont, and Pfizer." Lohr says the platform "uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical jo

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.